Cargando…
Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714456/ https://www.ncbi.nlm.nih.gov/pubmed/23875068 http://dx.doi.org/10.3802/jgo.2013.24.3.209 |
| _version_ | 1782277357382402048 |
|---|---|
| author | Pujade-Lauraine, Eric |
| author_facet | Pujade-Lauraine, Eric |
| author_sort | Pujade-Lauraine, Eric |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3714456 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-37144562013-07-19 Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer Pujade-Lauraine, Eric J Gynecol Oncol Editorial Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013-07 2013-07-04 /pmc/articles/PMC3714456/ /pubmed/23875068 http://dx.doi.org/10.3802/jgo.2013.24.3.209 Text en Copyright © 2013. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Pujade-Lauraine, Eric Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| title | Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| title_full | Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| title_fullStr | Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| title_full_unstemmed | Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| title_short | Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| title_sort | bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714456/ https://www.ncbi.nlm.nih.gov/pubmed/23875068 http://dx.doi.org/10.3802/jgo.2013.24.3.209 |
| work_keys_str_mv | AT pujadelauraineeric bevacizumabandoralmetronomiccyclophosphamideinplatinumresistantovariancancer |